RecruitingNCT05057403

UK Imaging Diabetes Study Seeing Diabetes Clearly


Sponsor

Perspectum

Enrollment

1,000 participants

Start Date

May 30, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

Prospective, observational cohort study to cross-sectionally assess the health of multiple organs, using multiparametric abdominal magnetic resonance imaging (MRI) scan, and understand if resulting MRI metrics can predict future clinical events over a period of 5 years, in adult patients with type 2 diabetes lacking history of cardiovascular disease.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying MRI for people with type2 diabetes. The study is currently recruiting participants at 12 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERMRI

MRI is not part of Pathway for patient with type two diabetes.


Locations(12)

Woodlands Medical Centre

Didcot, Oxfordshire, United Kingdom

Eynsham Medical Centre

Eynsham, Oxfordshire, United Kingdom

White Horse Medical Practice

Farringdon, Oxfordshire, United Kingdom

Windrush Medical Practice

Witney, Oxfordshire, United Kingdom

The House Partnership

Redhill, Surrey, United Kingdom

Swansea Bay University Health Board

Baglan, Swansea, United Kingdom

University Hospitals of Liverpool Group

Liverpool, United Kingdom

Moorfields Eye Hospital NHS Foundation Trust

London, United Kingdom

The Manor Group

Oxford, United Kingdom

Hedena Health

Oxford, United Kingdom

St Bartholomew and Hollow Way Medical Practice

Oxford, United Kingdom

Oxford Community Diagnostic centre

Oxford, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05057403


Related Trials